Bioterrorism

BIOGRAPHY

Itamar Shalit

Academic positions:
- Director of the Pediatric Infectious Disease Unit, Schneider Children's Hospital, Israel
- Former Director General of Schneider Children's Hospital and Carmel Hospital in Israel

Any industry positions (last five years):
Dr. Shalit's experience in research and clinical trials includes collaborations and consultancy for international pharmaceutical companies such as Bayer AG, Smith-Klein-Beecham, Eli Lilly, Glaxo Group Research and Miles Pharmaceuticals. He is also a scientific advisory board member for Bioline RX.

Research interests:
Dr Shalit's main areas of research include the study of immunomodulatory effects of quinolones, the study of anti-inflammatory and signal transduction mechanisms and study of novel anti-fungal agents and their combinations.

Any other information:
Dr. Shalit is a long-standing member of several Israel Ministry of Health committees focused on designing the national vaccination program, preparedness against bio-terrorism and eradication of poliomyelitis.

He received a Certificate of Appreciation from the World Health Organization (WHO) for his contribution and outstanding efforts and success in poliomyelitis eradication in Israel. Dr Shalit is the author of over 70 publications in leading scientific journals and chapters in textbooks and is currently Chairman of the Israeli Society for Infectious Diseases.